title: Enrollment of older adults on oncology trials: An FDA perspective.
authors.affiliation: Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States. Electronic address: Harpreet.Singh@fda.hhs.gov.
authors.forename: Harpreet
authors.initials: H
authors.lastname: Singh
authors.affiliation: Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
authors.forename: Julia A
authors.initials: JA
authors.lastname: Beaver
authors.affiliation: Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Kim
authors.affiliation: Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
authors.forename: Richard
authors.initials: R
authors.lastname: Pazdur
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000076722:Drug Development / Q000639:trends*; D006801:Humans; D008495:Medical Oncology; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D014481:United States; D014486:United States Food and Drug Administration